Methylergonovine

CHEMBL1201356 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
339.4 g/mol
LogP
2.3
Phase
4

A uterotonic medication used to prevent and treat excessive bleeding after childbirth (postpartum hemorrhage) by causing the uterus to contract. It is given by injection or by mouth immediately after delivery.

Peso Molecular

339,4000 g/mol

LogP

2,30

TPSA

68,40 Ų

Regra dos 5 de Lipinski

Aprovado

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1

InChI

InChI=1S/C20H25N3O2/c1-3-14(11-24)22-20(25)13-7-16-15-5-4-6-17-19(15)12(9-21-17)8-18(16)23(2)10-13/h4-7,9,13-14,18,21,24H,3,8,10-11H2,1-2H3,(H,22,25)/t13-,14+,18-/m1/s1

Molecular Formula

C20H25N3O2

HBD / HBA

3 / 3

Ligações Rotacionáveis

4

Átomos Pesados

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A uterotonic medication used to prevent and treat excessive bleeding after childbirth (postpartum hemorrhage) by causing the uterus to contract. It is given by injection or by mouth immediately after delivery.

Yes, Methylergonovine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201356. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 8226. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.